Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
Saved in:
| Title: | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going? |
|---|---|
| Authors: | Marshall MJE; Antibody and Vaccine Group, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, United Kingdom., Stopforth RJ; Antibody and Vaccine Group, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, United Kingdom., Cragg MS; Antibody and Vaccine Group, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2017 Oct 04; Vol. 8, pp. 1245. Date of Electronic Publication: 2017 Oct 04 (Print Publication: 2017). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2017.01245 |
